Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis
L Sichletidis, L Settas, D Spyratos… - … of Tuberculosis and …, 2006 - ingentaconnect.com
SETTING: A major concern surrounding the use of tumor necrosis factor-alpha (TNF-α) inhibitors
is their potential to increase the risk of opportunistic infections, particularly tuberculosis (…
is their potential to increase the risk of opportunistic infections, particularly tuberculosis (…
Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of …
…, PV Voulgari, KA Boki, I Papadopoulos, L Settas… - Seminars in arthritis and …, 2014 - Elsevier
… Boki MD c , Ioannis Papadopoulos MD d , Loukas Settas MD e , Dimitrios Zisopoulos MD
e f , Fotini N. Skopouli MD g , Alexios Iliopoulos MD h , George K. Bertsias MD a , Pierre …
e f , Fotini N. Skopouli MD g , Alexios Iliopoulos MD h , George K. Bertsias MD a , Pierre …
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: clinical efficacy, radiographic, and safety outcomes from a twenty‐four–month, phase …
…, J Rosa, Z Ruzga, L Settas… - Arthritis & …, 2019 - Wiley Online Library
Objective Tofacitinib is an oral JAK inhibitor for the treatment of rheumatoid arthritis ( RA ).
The phase III , 24‐month, placebo‐controlled Oral Rheumatoid Arthritis ( ORAL ) Scan trial …
The phase III , 24‐month, placebo‐controlled Oral Rheumatoid Arthritis ( ORAL ) Scan trial …
Longterm beneficial effect of canakinumab in colchicine-resistant familial Mediterranean fever
…, A Garyfallos, D Karokis, D Pikazis, L Settas… - The Journal of …, 2017 - jrheum.org
Objective. To assess the efficacy and safety of the interleukin-1β (IL-1β) inhibitor canakinumab
in all adolescent and adult patients with familial Mediterranean fever (FMF) identified from …
in all adolescent and adult patients with familial Mediterranean fever (FMF) identified from …
Comparative analysis and predictors of 10-year tumor necrosis factor inhibitors drug survival in patients with spondyloarthritis: first-year response predicts longterm …
…, FN Skopouli, PV Voulgari, L Settas… - The Journal of …, 2018 - jrheum.org
Objective. To evaluate the 10-year drug survival of the first tumor necrosis factor inhibitor (TNFi)
administered to patients with spondyloarthritis (SpA) overall and comparatively between …
administered to patients with spondyloarthritis (SpA) overall and comparatively between …
Reactivation of occult hepatitis B virus infection, following treatment of refractory rheumatoid arthritis with abatacept
…, P Hytiroglou, M Zakalka, L Settas - Journal of …, 2012 - journal-of-hepatology.eu
Abatacept is a biologic response modifier that is used in the treatment of refractory rheumatoid
arthritis. This agent is not known to be associated with reactivation of hepatitis B virus (…
arthritis. This agent is not known to be associated with reactivation of hepatitis B virus (…
Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study
…, D Parcharidou, H Karvounis, L Settas - Rheumatology …, 2011 - Springer
Systemic sclerosis is a connective tissue disease, which may lead to elevated pulmonary
arterial pressure due to pulmonary arterial hypertension and/or left ventricular diastolic …
arterial pressure due to pulmonary arterial hypertension and/or left ventricular diastolic …
Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and …
…, T Karamitsos, D Parcharidou, L Settas - The Journal of …, 2010 - jrheum.org
Objective. Cardiopulmonary complications are common in patients with systemic sclerosis (SSc).
We assessed cardiac involvement in patients with SSc using echocardiography and …
We assessed cardiac involvement in patients with SSc using echocardiography and …
[PDF][PDF] Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective real-life study
D Vassilopoulos, EM Delicha, L Settas… - Clin Exp …, 2016 - clinexprheumatol.org
… Delicha, PhD Loukas Settas, MD, Prof. Alexandros Andrianakos, MD Spyros Aslanidis,
MD Panagiota Boura, MD, Prof. Marios Katsounaros, MD Panagiotis Athanassiou, MD …
MD Panagiota Boura, MD, Prof. Marios Katsounaros, MD Panagiotis Athanassiou, MD …
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis
…, G Koliakos, A Garyfallos, I Styliadis, L Settas - Clinical …, 2010 - Springer
Early detection of pulmonary hypertension (PH) in patients with systemic sclerosis (SSc) is
essential as it leads to substantial morbidity and mortality irrespective of its etiology. The aim …
essential as it leads to substantial morbidity and mortality irrespective of its etiology. The aim …